DANIELLE ORSINI: Open Payments
NPI 1306286018 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$658 in 25 payments from 6 companies in 2025. Trend: 2023 $499 · 2024 $437 · 2025 $658
Food & beverage: $624Education: $34
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 16 | $431 |
| Amgen Inc. | 4 | $113 |
| Verona Pharma, Inc. | 2 | $50 |
| Lilly USA, LLC | 1 | $22 |
| Grifols USA, LLC | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
Products named: NUCALA, TEZSPIRE, Ohtuvayre, ZEPBOUND, TRELEGY ELLIPTA, Prolastin-C Liquid, FASENRA.
Industry payments across NY — which companies pay providers there.
